Reducing PSAnxiety: The importance of noninvasive chronic disease management in prostate cancer detection and treatment

American Journal of Medicine

Volumn 117, Issue 10, 2004, Pages 796-798

  Wilt, Timothy J ^a,b,c   Partin, Melissa R ^a  

^a Minneapolis VA Ctr Chron Dis O   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Minneapolis VA Ctr Chron Dis O   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; ANXIETY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHRONIC DISEASE; COUNSELING; DIAGNOSTIC ACCURACY; DISEASE MARKER; EDITORIAL; ERECTILE DYSFUNCTION; HORMONAL THERAPY; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COUNSELING; FALSE POSITIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 8344250877     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.10.002     Document Type: Editorial

References (23)

1. B.E. Sirovich, L.M. Schwartz, S. Woloshin Screening men for prostate and colorectal cancer in the United States Does practice reflect the evidence? JAMA 289 2003 1414 1420
2. R. Harris, K.N. Lohr Screening for prostate cancer An update of the evidence for the U.S. Preventive Services Task Force Ann Int Med. 137 2002 917 929
3. M.R. Partin, T.J. Wilt Informing patients about prostate cancer screening identifying and meeting the challenges while the evidence remains uncertain Am J Med. 113 2002 691 693
4. D.F. Ransohoff, M. McNaughton-Collins, F.J. Fowler Jr Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback Am J Med. 113 2002 663 669
5. M. McNaughton-Collins, F.J. Fowler, J.F. Caubet, D.W. Bates, J.M. Lee, A. Hauser, M.J. Barry Psychological impact of a suspicious prostate cancer screening test followed by a benign biopsy Am J Med. 117 2004 719 725
6. L. Cormier, F. Guillemin, A. Valeri Impact of prostate cancer screening on health-related quality of life in at-risk families Urology 59 2002 901 906
7. M.L. Essink-Bot, H.J. de Konig, H.G.T. Nijs, W.J. Kirkels, P.J. van der Maas, F.H. Schroder Short-Term effects of population-based screening for prostate cancer on health-related quality of life J Natl Cancer Inst. 90 1998 925 931
8. K.M. Kash, J.C. Holland, M.S. Halper, D.G. Miller Psychological distress and surveillance behaviors of women with a family history of breast cancer J Natl Cancer Inst. 84 1992 24 30
9. C. Lerman, K. Kash, M. Stefanek Younger women at increased risk for breast cancer perceived risk, psychological well-being, and surveillance behavior J Natl Cancer Inst Monogr. 16 1994 171 176
10. J. Erblich, D.J. Bowvberg, H.B. Valdimarsdottir Psychological distress, health beliefs, and frequency of breast self-examination J Behav Med. 23 2000 277 292
11. J.G. Elmore, M.B. Barton, V.M. Moceri Ten-year risk of false positive screening mammograms and clinical breast examinations N Engl J Med. 338 1998 1089 1096
12. J. Cullen, M.D. Schwartz, W.F. Lawrence, J.V. Selby, J.S. Mandleblatt Short-term impact of cancer prevention and screening activities on quality of life J Clin Onc. 22 2004 943 952
13. K.K. Lindfors, J. O'Connor, R.A. Parker False-positive screening mammograms Effect of immediate versus later work-up on patient stress Radiology 218 2001 247 253
14. L.M. Schwartz, S. Woloshin, F.J. Fowler, H.G. Welch Enthusiasm for cancer screening in the United States JAMA 291 2004 71 78
15. I.M. Thompson, D.K. Pauler, P.J. Goodman, C.M. Tangen, M.S. Jucia Prevalence of prostate cancer among men with a prostate specific antigen level ≤4.0 ng per milliliter NEJM 350 2004 2239 2246
16. R. Paul, S. Schöler, van Randenborgh, H. Kübler, M. Alschibaja, R. Busch, R. Hartung Morbidity of prostatic biopsy strategies Is there a relation to core number and sampling region? Eur Urol. 45 2004 450 456
17. M. McNaughton-Collins, D.F. Ransohoff, M.J. Barry Early detection of prostate cancer; Serendipity strikes again JAMA 278 1997 1516 1519
18. Hippocrates. Epidemics. Book I, Sect. XI.
19. H.G. Welch Should I be tested for cancer? Maybe not and here's why 2004 University of California Press Berkeley, CA
20. G. Draisma, R. Boer, S.J. Otto Lead times and overdetection due to prostate-specific antigen screening Estimates from the European Randomized study of screening for prostate cancer J Natl Cancer Inst. 95 2003 868 878
21. J.E. Johansson, O. Andren, S.-O. Andersson Natural history of early, localized prostate cancer JAMA 291 2004 2713 2719
22. I. Holmberg, A. Bill-Axelson, F. Helgesen A randomized trial comparing radical prostatectomy with watchful waitng in early prostate cancer N Engl J Med. 347 2002 781 789
23. A.V. D'Amico, J. Manola, M. Loffredo, A.A. Renshaw, A. Dellacroce, P.W. Kantoff 6-month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancerA randomized controlled trial JAMA 292 2004 821 827